Results 71 to 80 of about 5,941 (192)

FORMULATION AND EVALUATION OF RABEPRAZOLE SODIUM AND DOMPERIDONE PELLETS [PDF]

, 2017
The aim of present study was to formulate and evaluate Rabeprazole sodium and Domperidone pellets for the treatment of gastro esophageal reflux disease. Modified release drug delivery systems were capable of drug release when and where it requires.
P. Swathi*
core   +1 more source

The Influence of CYP2C19 Polymorphism on Eradication of Helicobacter pylori: A Prospective Randomized Study of Lansoprazole and Rabeprazole

Gut and Liver, 2010
Background/Aims: The CYP2C19 polymorphism plays an important role in the metabolism of various proton-pump inhibitors. Several trials have produced conflicting data on eradication rates of Helicobacter pylori (H. pylori) among CYP2C19 genotypes.
doaj   +1 more source

PRINCIPLES OF MANAGEMENT OF CHRONIC EZOPHAGITIS OF VARIOUS ETIOLOGIES

Медицинский совет, 2018
The article describes various etiological forms of esophagitis, such as reflux-induced, infectious: viral, fungal, bacterial, allergic, dysmetabolic, the one caused by systemic diseases, radiation, medicinal, eosinophilic.
E. Yu. Plotnikova, L. G. Vologzhanina, O. A. Igumnova, T. O. Kolmogorova   +3 more
doaj   +1 more source

Variability of 24-hour pH-metry scores at patients with duodenal peptic ulcer after single dose of rabeprazole

Российский журнал гастроэнтерологии, гепатологии, колопроктологии, 2010
Aim of investigation. To estimate antisecretory response to single dose of rabeprazole in patients with peptic ulcer (PUD) of duodenum by 24-hour intragastric pH-metry.Material and methods.
D. I. Abdulganiyeva
doaj  

A review of rabeprazole in the treatment of acid-related diseases

, 2007
Rabeprazole is a proton pump inhibitor. Pharmacodynamic data show rabeprazole can achieve optimal acid suppression since the first administration and can maintain this advantage in the following days of therapy. Moreover, rabeprazole has the highest pKa (
F. Pace, S. Pallotta, G. Bianchi Porro, S. Canalini   +3 more
core   +2 more sources

Efficacy of Shugan Hewei formula combined with rabeprazole in refractory gastroesophageal reflux disease: randomized, double-blind, placebo-controlled trial

European Journal of Medical Research
Objectives To assess the efficacy of the Chinese herbal medication Shugan Hewei formula (SHF) combined with rabeprazole in patients with refractory gastroesophageal reflux disease (rGERD).
Xiulian Zhang, Zhongfu Wang, Tingting Xu, Lei Wei, Fangying Liu, Chunfang Liu, Li Li, Wei Zhang, Shengliang Zhu   +8 more
doaj   +1 more source

Tonghua Liyan granules in the treatment of Laryngopharyngeal reflux disease with stagnation of phlegm and qi syndrome: a randomized, double-blind, placebo-controlled study

Frontiers in Pharmacology
Background: Laryngopharyngeal reflux disease (LPRD) is an extraesophageal syndromic manifestation of gastroesophageal reflux disease (GERD). Despite the increasing incidence of and concern about LPRD, treatment with proton pump inhibitors (PPIs) is ...
Yading Li, Yading Li, Mingxian Zheng, Yi Wang, Gaofan Xu, Yunyun He, Yue Wu, Xiao Wang, Yuyang Liu, Yujie Jiang, Xiaowen Liu, Yangyang Meng, Yixuan Yap, Shengliang Zhu, Cong He, Bingduo Zhou   +15 more
doaj   +1 more source

Formulation and evaluation of sustained release matrix tablet of rabeprazole using wet granulation technique

Journal of Pharmacy and Bioallied Sciences, 2014
Introduction: Rabeprazole, a member of substituted benzimidazoles, inhibits the final step in gastric acid secretions. This drug claims to cause fastest acid separation (due to higher pKa), and more rapidly converts to the active species to aid gastric ...
Ruqaiyah Khan, Md Shamim Ashraf, Muhammad Afzal, Imran Kazmi, Mohammed Asadullah Jahangir, Rajbala Singh, Ramesh Chandra, Firoz Anwar   +7 more
doaj   +1 more source

The comparative effect of rabeprazole vs. omeprazole on gastric acid and mucoid-electrolite secretion in patients with peptic ulcer disease

Current Issues in Pharmacy and Medical Sciences, 2010
Rabeprazole provides superior acid suppression and inhibits pepsin release in comparison to omeprazole. Better ulcer healing results after management by rabeprazole are caused by its gastric mucosa protecting effect in compare with omeprazole.
Helena Sklyarova, Irena Shalko
doaj  

Efficacy of rabeprazole for the treatment of gastroesophageal reflux disease in a 7-day non-interventional trial [PDF]

Терапевтический архив
Aim. To evaluate the efficacy of seven-day treatment with rabeprazole (Razo®) 20 mg once daily in patients with NERD and esophagitis based on monitoring the results of pH-impedancemetry of the stomach and esophagus and assessment of clinical symptoms.
Vladislav V. Tsukanov, Elena V. Onuchina, Alexander V. Vasyutin, Bairma B. Dambaeva, Julia L. Tonkikh, Nadezhda V. Pavlova   +5 more
doaj   +1 more source